NCT00017017View on ClinicalTrials.gov

CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2001

Primary Completion Date

February 28, 2003

Study Completion Date

December 31, 2009

Conditions
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Interventions
DRUG

paclitaxel poliglumex

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00017017 - CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter